1003-3734
2013 Issue 3
Preparation and in vitro evaluation of saponins PD-loaded Eudragit S100 nanoparticles
GENG Li-juan;TANG Li-hua;YOU Ben-gang;SHAO Yi-nan;LI Ling
GENG Li-juan;TANG Li-hua;YOU Ben-gang;SHAO Yi-nan;LI Ling
..............page:367-372
Detection of bacterial endotoxin in milrinone injection by the method of kinetic turbidimetric limulus test
ZHU Qing-fen;GUO Ming;WEI Xia;LI Tao
ZHU Qing-fen;GUO Ming;WEI Xia;LI Tao
..............page:355-358
Pharmacological and clinical evaluation of taliglucerase alfa for the treatment of type 1 Gaucher’s disease
ZHANG Ai-ling1;2;SHI Ai-xin2;XIE Jing1;2;HU Xin2
ZHANG Ai-ling1;2;SHI Ai-xin2;XIE Jing1;2;HU Xin2
..............page:253-255,259
Determination of the content of cefuroxime lysine bulk drug by HPLC method
WANG Jie;LI Qing;XU Shan-shan;CHEN Xiao-hui;ZHAO Long-shan;BI Kai-shun
WANG Jie;LI Qing;XU Shan-shan;CHEN Xiao-hui;ZHAO Long-shan;BI Kai-shun
..............page:359-363
Advance in research of paroxetine controlled-release tablets,a new formulation antidepressant
WANG Xue-qin;ZHANG Hong-yan
WANG Xue-qin;ZHANG Hong-yan
..............page:313-318
Developments in research of the anti-hepatitis C viral effects of silymarin
LIANG Jing;HAN Tao
LIANG Jing;HAN Tao
..............page:323-325,330
Different doses of dexmedetomidine used for sedation in lower limb operation under combined spinal-epidural anesthesia
YANG Zi-juan;ZHANG Xing-an;HU Bo;SHAO Wei-dong;XU Bo;TU Wei-feng
YANG Zi-juan;ZHANG Xing-an;HU Bo;SHAO Wei-dong;XU Bo;TU Wei-feng
..............page:326-330
Preparation of ibuprofen ethosomes and their in vitro transdermal peneatration
YUAN Hai-ling1;2;HU Ji-min2;WEI Yu-hui1;ZHANG Jian-ping1;ZHOU Yan1;WU Xin-an1
YUAN Hai-ling1;2;HU Ji-min2;WEI Yu-hui1;ZHANG Jian-ping1;ZHOU Yan1;WU Xin-an1
..............page:351-354,363
Preparation and property evaluation in vitro of 10-hydroxycamptothecin cationic polymer nanoparticles
YANG Jing-an;LI Juan;WANG Jing
YANG Jing-an;LI Juan;WANG Jing
..............page:274-278
Rheological characteristics of nifeviroc vaginal thermosensitive in situ gels
TIAN Fang1;WANG Yu-zhu1;YANG Kai2;WEN Cheng-li1;CHENG Qian-qian1;LI Wei-hua1;DING Xun-cheng1 Co.;Ltd.;Shanghai 200233;China)
TIAN Fang1;WANG Yu-zhu1;YANG Kai2;WEN Cheng-li1;CHENG Qian-qian1;LI Wei-hua1;DING Xun-cheng1 Co.;Ltd.;Shanghai 200233;China)
..............page:345-350
Evaluation of clinical application of bevacizumab in our hospital in 2011
ZHANG Wen1;WANG Qian2;TANG Lin2;ZHANG Jian1
ZHANG Wen1;WANG Qian2;TANG Lin2;ZHANG Jian1
..............page:336-338,350
Microenvironmental pH modulation based stability improvement of rabeprazole sodium
JIN Xin1;2;WANG Yu-li1;SHAN Li1;YANG Mei-yan1;GAO Chun-sheng1
JIN Xin1;2;WANG Yu-li1;SHAN Li1;YANG Mei-yan1;GAO Chun-sheng1
..............page:279-283
Research progress in biomarkers of drug-induced liver injury
KONG Ming;DAI Jing;SUN Yi;GAO Ting-ting;MA Xiu-juan;MAO Yu;ZHANG Xiao-dong; GONG Xue-lian;JIANG Hua;YUAN Bo-jun;LU Guo-cai
KONG Ming;DAI Jing;SUN Yi;GAO Ting-ting;MA Xiu-juan;MAO Yu;ZHANG Xiao-dong; GONG Xue-lian;JIANG Hua;YUAN Bo-jun;LU Guo-cai
..............page:290-293
Analysis of connection between patent system and protection of traditional Chinese medicine resources
CAO Li-rong
CAO Li-rong
..............page:263-268
Establishment of the quality standard of rheumatism ostalgia spray Ⅲ
ZHOU Xiao-lei1;YUAN Jing-quan1;2;FAN Xi-yuan1;GONG Xiao-mei1;MO Dan-dan1;WANG Shuo1;3
ZHOU Xiao-lei1;YUAN Jing-quan1;2;FAN Xi-yuan1;GONG Xiao-mei1;MO Dan-dan1;WANG Shuo1;3
..............page:364-366,372
Discussion and case analysis of clinical development strategy of small-molecule targeted anti-cancer drugs
CHEN Xiao-yuan;ZHANG Hong;GAO Chen-yan;YANG Zhi-min
CHEN Xiao-yuan;ZHANG Hong;GAO Chen-yan;YANG Zhi-min
..............page:269-273
Neuroprotective effects of intracerebroventricular administration of DJ-1 protein on MPTP-induced Parkinson’s disease in mice
SUN Shuang-yong1;2;ZHOU Jun-jun1;2;DENG Zheng1;2;AN Chun-na1;2;ZHAO Xin1;2;PU Xiao-ping1;2
SUN Shuang-yong1;2;ZHOU Jun-jun1;2;DENG Zheng1;2;AN Chun-na1;2;ZHAO Xin1;2;PU Xiao-ping1;2
..............page:339-344
Analysis of essential drug selection principles of China
CHAI Yue1;GUAN Xiao-dong1;2;XIN Xiao-xiong1;SHI Lu-wen1;2
CHAI Yue1;GUAN Xiao-dong1;2;XIN Xiao-xiong1;SHI Lu-wen1;2
..............page:260-262,268
Pharmacokinetic comparison of metronidazole colon-targeted sustained-release tablets with conventional tablets in healthy volunteers
MAO Rui1;2;XU Nan1;QIN Yong-ping1;WANG Ying1;NAN Feng1;XIANG Jin1;YU Qin1;LIANG Mao-zhi1
MAO Rui1;2;XU Nan1;QIN Yong-ping1;WANG Ying1;NAN Feng1;XIANG Jin1;YU Qin1;LIANG Mao-zhi1
..............page:331-335
bian zhe tui jian
wang yu mei
wang yu mei
..............page:248
Progress in clinical study of histone deacetylases inhibitors as anticancer agents
YAO Yi-wu1;2;YAO He-quan1;JIANG Sheng2;XUE Xiao-wen1
YAO Yi-wu1;2;YAO He-quan1;JIANG Sheng2;XUE Xiao-wen1
..............page:294-300
Introduction and understanding of domestic and abroad regulations on clinical trials of pediatric drugs
LU Yao-wen;SUN Tian-yu;DENG Gui-xing;LIN Rong;LIN Song;WANG Ting
LU Yao-wen;SUN Tian-yu;DENG Gui-xing;LIN Rong;LIN Song;WANG Ting
..............page:256-259
Recent progress in research on anthracyclines
HAN Chong1;ZHU Xiong2;XU Yun-gen1
HAN Chong1;ZHU Xiong2;XU Yun-gen1
..............page:307-312,335
Research progress in α-conotoxins targeting nicotinic acetylcholine receptors
FANG Li-cong;SHEN Li-zi;YU Jin-peng;ZHU Xiao-peng;HU Yuan-yan;ZHANG Ben; ZHANGSUN Dong-ting;LUO Su-lan
FANG Li-cong;SHEN Li-zi;YU Jin-peng;ZHU Xiao-peng;HU Yuan-yan;ZHANG Ben; ZHANGSUN Dong-ting;LUO Su-lan
..............page:284-289
..............page:251-252
Research progress in derivatives of the tubulin inhibitor combretastatin A-4
XU Qin-long;ZHOU Peng;LI Jia-ming;ZHANG En-li;YE Wen-feng
XU Qin-long;ZHOU Peng;LI Jia-ming;ZHANG En-li;YE Wen-feng
..............page:301-306,318
Overview of drug resistence and clinical studies of ixabepilone
GU Jue-fen;ZHANG Peng-cheng
GU Jue-fen;ZHANG Peng-cheng
..............page:319-322,344